Use of targeted therapies for advanced renal cell carcinoma in the Asia-Pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia.

MLA

Ye, Dingwei, et al. “Use of Targeted Therapies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement from China, Japan, Taiwan, Korea, and Australia.” Clinical Genitourinary Cancer, vol. 12, no. 4, Aug. 2014, pp. 225–33. EBSCOhost, https://doi.org/10.1016/j.clgc.2014.01.007.

APA

Ye, D., Eto, M., Chung, J. S., Kimura, G., Chang, W.-C., Chang, Y.-H., Pang, S.-T., Lee, J. L., Niu, Y., Gurney, H., & Uemura, H. (2014). Use of targeted therapies for advanced renal cell carcinoma in the Asia-Pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia. Clinical Genitourinary Cancer, 12(4), 225–233. https://doi.org/10.1016/j.clgc.2014.01.007

Chicago

Ye, Dingwei, Masatoshi Eto, Jin Soo Chung, Go Kimura, Wen-Cheng Chang, Yen-Hwa Chang, See-Tong Pang, et al. 2014. “Use of Targeted Therapies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement from China, Japan, Taiwan, Korea, and Australia.” Clinical Genitourinary Cancer 12 (4): 225–33. doi:10.1016/j.clgc.2014.01.007.